Mill Capital Management’s AbbVie ABBV Stock Holding History

Mill Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$962K	Hold	4,422	–	–	0.07%	80
2025 Q4	$1.01M	Buy	4,422 +40	+0.9%	+$9.11K	0.07%	81
2025 Q3	$1.01M	Hold	4,382	–	–	0.08%	78
2025 Q2	$813K	Hold	4,382	–	–	0.06%	81
2025 Q1	$918K	Hold	4,382	–	–	0.07%	81
2024 Q4	$779K	Hold	4,382	–	–	0.06%	82
2024 Q3	$865K	Hold	4,382	–	–	0.07%	81
2024 Q2	$752K	Hold	4,382	–	–	0.06%	84
2024 Q1	$798K	Hold	4,382	–	–	0.07%	85
2023 Q4	$679K	Hold	4,382	–	–	0.06%	89
2023 Q3	$653K	Hold	4,382	–	–	0.06%	89
2023 Q2	$590K	Hold	4,382	–	–	0.06%	92
2023 Q1	$698K	Hold	4,382	–	–	0.07%	86
2022 Q4	$708K	Hold	4,382	–	–	0.08%	83
2022 Q3	$588K	Sell	4,382 -198	-4%	-$28.4K	0.07%	85
2022 Q2	$701K	Hold	4,580	–	–	0.08%	82
2022 Q1	$742K	Buy	4,580 +198	+5%	+$28.8K	0.07%	89
2021 Q4	$593K	Buy	+4,382	New	+$518K	0.06%	78

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mill Capital Management's ABBV Position: Q1 2026 in Review

Mill Capital Management held its AbbVie (ABBV) position steady in Q1 2026 at 4,422 shares worth $962K. The position accounts for 0.07% of the portfolio, ranked #80.

Mill Capital Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.01M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Mill Capital Management held 4,422 shares of AbbVie worth $962K as of Q1 2026.
Mill Capital Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.07% of Mill Capital Management's portfolio in Q1 2026, its #80 holding.
Mill Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
Mill Capital Management's AbbVie position peaked at $1.01M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mill Capital Management's 13F filing for Q1 2026, filed 4 May 2026.